BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24368725)

  • 21. Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting.
    Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
    Med Sci Monit; 2000; 6(4):708-12. PubMed ID: 11208396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial.
    Stähli BE; Gebhard C; Duchatelle V; Cournoyer D; Petroni T; Tanguay JF; Robb S; Mann J; Guertin MC; Wright RS; L L'Allier P; Tardif JC
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection by atorvastatin pretreatment in patients undergoing primary percutaneous coronary intervention is associated with the lower levels of oxygen free radicals.
    Chen M; Li H; Wang Y
    J Cardiovasc Pharmacol; 2013 Sep; 62(3):320-4. PubMed ID: 23714773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracoronary administration of darbepoetin-alpha at onset of reperfusion in acute myocardial infarction: results of the randomized Intra-Co-EpoMI trial.
    Roubille F; Micheau A; Combes S; Thibaut S; Souteyrand G; Cayla G; Bonello L; Lesavre N; Sportouch-Dukhan C; Klein F; Berboucha S; Cade S; Cung TT; Raczka F; Macia JC; Gervasoni R; Cransac F; Leclercq F; Barrère-Lemaire S; Paganelli F; Mottref P; Vernhet Kovacsik H; Ovize M; Piot C
    Arch Cardiovasc Dis; 2013 Mar; 106(3):135-45. PubMed ID: 23582675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
    Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
    J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting.
    Peker O; Peker T; Erdogan D; Ozaydin M; Kapan S; Sutcu R; Ibrisim E
    J Cardiovasc Surg (Torino); 2008 Aug; 49(4):527-31. PubMed ID: 18665117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Bagai A; Schulte PJ; Granger CB; Mahaffey KW; Christenson RH; Bell G; Lopes RD; Green CL; Lincoff AM; Armstrong PW; Roe MT
    Am Heart J; 2014 Oct; 168(4):503-511.e2. PubMed ID: 25262260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT Study.
    Abouzaki NA; Christopher S; Trankle C; Van Tassell BW; Carbone S; Mauro AG; Buckley L; Toldo S; Abbate A
    J Cardiovasc Pharmacol; 2018 Jun; 71(6):375-379. PubMed ID: 29634656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of fragmented QRS complexes in prediction of myocardial infarction and reperfusion parameters in patients undergoing primary percutaneous coronary intervention.
    Kocaman SA; Çetin M; Kırış T; Erdoğan T; Çanga A; Durakoğlugil E; Şatıroğlu Ö; Şahinarslan A; Çiçek Y; Sahin İ; Bostan M
    Turk Kardiyol Dern Ars; 2012 Apr; 40(3):213-22. PubMed ID: 22864316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of intravenous lidocaine on myocardial injury after off-pump coronary artery surgery.
    Lee EH; Lee HM; Chung CH; Chin JH; Choi DK; Chung HJ; Sim JY; Choi IC
    Br J Anaesth; 2011 Apr; 106(4):487-93. PubMed ID: 21343159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The myocardial protective effect of adenosine as an adjunct to intermittent blood cardioplegia during open heart surgery.
    Liu R; Xing J; Miao N; Li W; Liu W; Lai YQ; Luo Y; Ji B
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1018-23. PubMed ID: 19683936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weak diagnostic performance of troponin, creatine kinase and creatine kinase-MB to diagnose or exclude myocardial infarction after successful resuscitation.
    Kruse JM; Enghard P; Schröder T; Hasper D; Kühnle Y; Jörres A; Storm C
    Int J Cardiol; 2014 May; 173(2):216-21. PubMed ID: 24636545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury.
    Gustavsson CG; Hansen O; Frennby B
    Scand Cardiovasc J; 2004 May; 38(2):75-9. PubMed ID: 15204231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
    Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.
    Park H; Otani H; Noda T; Sato D; Okazaki T; Ueyama T; Iwasaka J; Yamamoto Y; Iwasaka T
    Int J Cardiol; 2013 Aug; 167(4):1547-51. PubMed ID: 22608892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of short-term celecoxib before elective percutaneous coronary intervention for stable angina pectoris.
    Pelliccia F; Pasceri V; Granatelli A; Pristipino C; Speciale G; Roncella A; Cianfrocca C; Mercuro G; Richichi G
    Am J Cardiol; 2006 Dec; 98(11):1461-3. PubMed ID: 17126650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.
    Yun KH; Jeong MH; Oh SK; Rhee SJ; Park EM; Lee EM; Yoo NJ; Kim NH; Ahn YK; Jeong JW
    Int J Cardiol; 2009 Nov; 137(3):246-51. PubMed ID: 18706705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.